S. J. Machin

The use of an anti‐β2‐glycoprotein‐I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis

D. Isenberg, I. Mackie, I. Mackie, 1995, British journal of haematology.

Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?

H. Cohen, S. Machin, S. Machin, 2010, Lupus.

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

D. Isenberg, C. Doré, M. Khamashta, 2016, The Lancet. Haematology.

Diagnosis of antiphospholipid syndrome in routine clinical practice

H. Cohen, S. Machin, J. Hills, 2013, Lupus.

The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction

S. Austin, H. Cohen, I. Mackie, 2008, British journal of haematology.

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

D. Isenberg, H. Cohen, I. Mackie, 2015, Journal of thrombosis and haemostasis : JTH.

Factor XIII – an under diagnosed deficiency – are we using the right assays?

R. Liesner, Ian J. Mackie, Anthony Lawrie, 2010, Journal of thrombosis and haemostasis : JTH.

Evaluation of the Sysmex XN‐550, a Novel Compact Haematology analyser from the XN‐L® series, compared to the XN‐20 system

I. Mackie, S. Machin, A. Mellick, 2017, International journal of laboratory hematology.